SCHEMBL10109443

SCHEMBL10109443

O=c1[nH]c2ccc(C3=NN(CCCl)CC3)cc2o1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
NR3C2 P08235 4/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
KCNH2 Q12809 1/20 0.41
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
NOS1 P29475 1/20 0.39
ALPL P05186 1/20 0.39
HPGD P15428 1/20 0.39
CDC7 O00311 1/20 0.38
CCNE1 P24864 1/20 0.38
CDK2 P24941 1/20 0.38
DBF4 Q9UBU7 1/20 0.38
ENPP2 Q13822 1/20 0.38
PPM1D O15297 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10109459 0.88 PDE3B (0.46) PDE3BPDE3ANR3C2KDM4EALDH1A1
SCHEMBL16239871 0.81 ENPP2 (0.44) PDE3BPDE3ANR3C2KCNH2SLC6A2
SCHEMBL356298 0.75 ENPP2 (0.65) KCNH2ENPP2
SCHEMBL118637 0.73 PDE3B (0.44) PDE3BPDE3ANR3C2KCNH2SLC6A2
SCHEMBL118692 0.71 GRIN1 (0.45) MEN1KMT2ACDC7CCNE1CDK2
SCHEMBL7766405 0.63 KDM4E (0.58) PDE3BPDE3AKDM4EALDH1A1MEN1
SCHEMBL17260655 0.63 PDE3B (0.71) PDE3BPDE3AKDM4EALDH1A1MEN1
SCHEMBL17260657 0.62 PDE3B (0.69) PDE3BPDE3ANR3C2KDM4EALDH1A1
SCHEMBL3700355 0.62 HTR1A (0.56) PDE3BPDE3AMEN1KMT2A
SCHEMBL4675522 0.62 KDM4E (0.52) PDE3BPDE3AKDM4EALDH1A1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2414327-B1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2014-11-19 EP disclosed
US-8841324-B2 Heterocyclic compounds as autotaxin inhibitors MERCK PATENT GMBH (DE) 2014-09-23 US disclosed
US-20120015959-A1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-19 US disclosed
WO-2010112116-A1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS MERCK PATENT GMBH (DE) 2010-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015959-A1 HETEROCYCLIC COMPOUNDS AS AUTOTAXIN INHIBITORS ENPP2, HAX1, MTX1 PDE3B 4254/4885PDE3A 3740/4885NR3C2 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.